Paper Details

  1. Home
  2. Paper Details

Psychotherapeutics and serotonin agonists and antagonists.

Author: MertzHoward

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Current treatments for irritable bowel syndrome (IBS) include antidepressants, psychotherapy, and agents targeted at receptors in the enteric nervous system, such as alosetron and tegaserod.
Paper Details　
Original Abstract of the Article :
Treatment of irritable bowel syndrome (IBS) remains challenging for patients and practitioners. Current therapeutic choices include antidepressants and psychotherapy, which are thought to target central nervous system triggers of symptoms. Data supporting these treatments are reviewed. Therapeutic a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/01.mcg.0000156113.14974.f5

データ提供：米国国立医学図書館（NLM）

Navigating the Labyrinth of Irritable Bowel Syndrome

Irritable bowel syndrome (IBS), a common gastrointestinal disorder, is like a labyrinth of discomfort, characterized by abdominal pain, bloating, and changes in bowel habits. The researchers in this study are exploring new treatments for IBS, seeking a way to unravel this labyrinth and provide relief for those who suffer from it. They are examining the role of serotonin, a chemical messenger in the gut, and its potential to influence symptoms.

New Approaches to IBS Treatment

The researchers are investigating the effectiveness of drugs that target serotonin receptors in the gut, such as alosetron and tegaserod. They are exploring different pathways, like finding new paths through the labyrinth, to potentially alleviate IBS symptoms.

Finding Relief in the Labyrinth

This research offers a glimmer of hope for individuals struggling with IBS. The exploration of serotonin-based treatments is like finding a new map to navigate the labyrinth of IBS symptoms. It's important to consult with a healthcare professional to determine the most effective treatment plan for your individual needs.

Dr.Camel's Conclusion

This research highlights the ongoing quest for effective treatments for IBS. It's like exploring a labyrinth, searching for pathways that lead to relief and improved quality of life. The investigation of serotonin-based therapies offers a promising avenue for finding solutions to this challenging condition.

Date :
  1. Date Completed 2005-08-11
  2. Date Revised 2019-08-17
Further Info :

Pubmed ID

15798492

DOI: Digital Object Identifier

10.1097/01.mcg.0000156113.14974.f5

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.